Search
Close this search box.
Logo Asphalion
Nitrosamines Risk Assessment

Nitrosamines Risk Assessment – Deadlines & Updates

Updates that allow pharmaceutical companies from now on to define a common strategy for the Nitrosamines Risk Assessment process.

Updates that allow pharmaceutical companies from now on to define a common strategy for the Nitrosamines Risk Assessment process.
October 14, 2020

Background:

In both 2018 and 2019 the presence of N-nitrosamines was found in sartans with a tetrazole ring but it was also detected in other API/medicinal products (e.g. in some batches of pioglitazone and ranitidine). Since N-nitrosamines are probable human carcinogens, the presence of these compounds in human medicinal products should be mitigated as much as possible.

Updates:

  • To allow Marketing Authorisation Holders (MAHs) enough time to implement the Article 5(3) opinion, the European medicines regulatory network agreed new deadlines: MAHs should perform a risk evaluation to determine whether chemically synthesized active pharmaceutical ingredients (APIs) are at risk for containing nitrosamines by March 31st, 2021. Products containing biological APIs should undergo this first step in risk evaluation by the 1st of July, 2021.
  • On September the 1st, 2020 the Food and Drug Administration (FDA) announced the availability of a guidance for industry, entitled “Control of N-Nitrosamine Impurities in Human Drugs.” This guidance recommends steps manufacturers of APIs and drug products should take to detect and prevent objectionable levels of nitrosamine impurities in pharmaceutical products. The guidance also describes conditions that may introduce nitrosamine impurities.

The above updates allow pharmaceutical companies from now on to define a common strategy for the Nitrosamines Risk Assessment process.

Asphalion can give you support in the preparation of the Risk Assessment for presence of Nitrosamine content.

We offer a global service that covers risk analysis, analytical phase and includes regulatory support with variation management. The end of the year is around the corner, so do not hesitate to contact us at info@asphalion.com in order to obtain specialized advisory and support!

Asphalion is here to help you!

Search News & Events

  • Filter by category

Share

Related news and events

Christmas season greatings

Season’s Greetings

We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting